Prescription medication · Progestin-Only Oral Contraceptive
norethindrone
Also sold as Camila, Errin. These pills are used to prevent pregnancy.
Data updated 2026-05-15
- 5,342
- FDA reportsLightly reported
- 10
- InteractionsSeveral interactions
- $0.08
- Generic price (NADAC)
What the data shows
norethindrone (Camila) is a prescription Progestin-Only Oral Contraceptive, reported less often than most tracked drugs (5,342 FDA reports), with 10 documented drug interactions.
Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.
norethindrone (Camila) is a prescription Progestin-Only Oral Contraceptive. These pills are used to prevent pregnancy.
Camila and Errin are progestin-only birth control pills. They help prevent pregnancy.
Verify with FDA → · CMS NADAC pricing →
Drug Pricing (NADAC)
Generic Price
$0.08/unit
Generic Available
Yes (86 manufacturers)
Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →
What it does
These pills are used to prevent pregnancy.
Common side effects
Nausea, Vomiting, Gastrointestinal symptoms (like cramps and bloating)
Key warnings
Cigarette smoking increases your risk of serious heart problems from birth control pills.
The sections below are summarized in plain English from norethindrone's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
Camila and Errin contain a progestin hormone. This hormone prevents pregnancy by stopping ovulation (the release of an egg from the ovary). It also thickens cervical mucus, making it harder for sperm to reach the egg.
Side Effects (from patient reports)
Based on 5,342 FDA adverse event reports.
Most-reported reactions
Adverse reactions in FAERS for norethindrone, by number of reports
- Nausea
Nausea
449 reports
- Headache
Headache
424 reports
- Hot Flush
Hot Flush
370 reports
- Fatigue
Fatigue
322 reports
- Pain
Pain
308 reports
- Vaginal Haemorrhage
Vaginal Haemorrhage
278 reports
- Abdominal Pain
Abdominal Pain
268 reports
- Arthralgia
Arthralgia
228 reports
- Diarrhoea
Diarrhoea
224 reports
- Dizziness
Dizziness
221 reports
What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.
Reports over time
Adverse-event reports filed for norethindrone each year to the FDA Adverse Event Reporting System (FAERS).
Year-to-year volume tracks usage, prescribing, and scrutiny, not a change in per-patient risk. Source: FDA FAERS.
Where norethindrone sits
norethindrone has more FDA adverse-event reports than 26% of the drugs FAERS tracks. A high position reflects how widely a drug is used and watched, not how dangerous it is.
Percentile across all drugs PlainMeds tracks by FAERS report volume. The dot is norethindrone; the line is the median (50th percentile).
FDA Adverse Event Report Analysis
Detailed analysis of 5,342 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2004–2025.
Total Reports
5,342
Reports Mentioning Death
80
1.5% of reports — not proof of cause
Hospitalization Reports
945
Top Indication
Product Used For Unknown Indication
Gender Distribution
Age Distribution
Most Reported Adverse Reactions (FAERS)
| # | Reaction | Reports |
|---|---|---|
| 1 | NAUSEA | 449 |
| 2 | HEADACHE | 424 |
| 3 | HOT FLUSH | 370 |
| 4 | FATIGUE | 322 |
| 6 | PAIN | 308 |
| 8 | VAGINAL HAEMORRHAGE | 278 |
| 9 | ABDOMINAL PAIN | 268 |
| 10 | ARTHRALGIA | 228 |
| 11 | DIARRHOEA | 224 |
| 12 | DIZZINESS | 221 |
| 13 | ANXIETY | 204 |
| 14 | MIGRAINE | 202 |
| 15 | DEPRESSION | 199 |
| 16 | VOMITING | 199 |
| 17 | PELVIC PAIN | 181 |
Reactions in Death Reports
Reactions in Hospitalization Reports
Source: FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation
Serious Warnings
Cigarette smoking increases your risk of serious heart problems from birth control pills. This risk is higher if you are over 35 and smoke. You should not take this medication if you are over 35 and smoke.
Known Drug Interactions
John's Wort (CYP450 inducer; P-gp inducer) Significantly Reduced Contraindicated Oral Contraceptives containing ethinyl estradiol and norethindrone (CYP2C19 Inhibition) Increased Monitoring for adverse reactions and toxicity related to voriconazole is recommended when coadministered with oral contraceptives. Oral Contraceptives containing ethinyl estradiol and norethindrone (CYP3A4 Inhibition) Increased Monitoring for adverse reactions related to oral contraceptives is recommended during coadministration.
Mechanism: Voriconazole slows down the process your body uses to get rid of the birth control pill. This can lead to higher levels of the birth control in your blood and increase your risk of side effects.
Oral Contraceptives: May increase plasma levels of norethindrone and ethinyl estradiol; consider this effect when selecting an oral contraceptive (7.3 ). Table 4: Atorvastatin Effects on Other Drugs Oral Contraceptives Clinical Impact: Co-administration of atorvastatin and an oral contraceptive increased plasma concentrations of norethindrone and ethinyl estradiol [see Clinical Pharmacology (12.3) ].
Mechanism: Taking atorvastatin can raise the levels of this hormone in your bloodstream.
Drug Interactions: Pharmacokinetic Parameters for Colchicine Tablets in the Presence of the Coadministered Drug Coadministered Drug Dose of Coadministered Drug (mg) Dose of Colchicine Tablets (mg) N % Change in Colchicine Concentrations from Baseline (Range: Min – Max) C max AUC 0-t Cyclosporine 100 mg single dose 0.6 mg single dose 23 270.0 (62.0 to 606.9) 259.0 (75.8 to 511.9) Clarithromycin 250 mg twice daily, 7 days 0.6 mg single dose 23 227.2 (65.7 to 591.1) 281.5 (88.7 to 851.6) Ketoconazole 200 mg twice daily, 5 days 0.6 mg single dose 24 101.7 (19.6 to 219.0) 212.2 (76.7 to 419.6)...
Mechanism: There is no known significant interaction between these two medications. They do not interfere with how each other is processed by the body.
7 DRUG INTERACTIONS Concomitant use with colesevelam hydrochloride may decrease the exposure of the following drugs: Drugs with a narrow therapeutic index (e.g., cyclosporine), phenytoin, thyroid hormone replacement therapy, warfarin, oral contraceptives containing ethinyl estradiol and norethindrone, olmesartan medoxomil, and sulfonylureas (glimepiride, glipizide, glyburide). Oral Contraceptives Containing Ethinyl Estradiol and Norethindrone Clinical Impact: In vivo drug interactions studies showed a decrease in exposure of ethinyl estradiol and norethindrone when coadministered with...
Mechanism: Colesevelam can reduce the amount of birth control medicine that enters your body. This happens because the drug can trap the birth control in your digestive system before it can work.
ethinyl estradiol, norethindrone, drospirenone ↓ ethinyl estradiol ↓ norethindrone drospirenone: effects unknown For co-administration with drospirenone, clinical monitoring is recommended due to the potential for hyperkalemia.
Mechanism: Darunavir can lower the amount of birth control hormones in your body, which might make the medication less effective.
This is a plain-language summary of FDA-label interaction records and does not provide individual medication-combination directions.
Common Questions
What if I experience breakthrough bleeding?
Can this pill cause weight gain?
Will this pill protect me from STIs?
What should I do if I vomit after taking the pill?
Can I still get pregnant if I take this pill?
Will this pill affect my mood?
Can I take this pill if I have high blood pressure?
Does this pill have any effect on my cholesterol?
Can I take this pill if I have a history of blood clots?
What if I want to stop taking this pill?
What are the common side effects of norethindrone?
Does norethindrone interact with other medications?
What drug class is norethindrone?
What pregnancy or breastfeeding source fields are listed for norethindrone?
Related Medications in Progestin-Only Oral Contraceptive
Other drugs grouped near norethindrone - same-class peers and common alternatives.
abiraterone
Zytiga
Abiraterone (Zytiga) is a medicine used with prednisone to treat prostate cancer that has spread.
Compare with norethindrone →
anastrozole
Arimidex
Anastrozole is a medicine used to treat breast cancer in women after menopause.
Compare with norethindrone →
bazedoxifene/conjugated estrogens
Duavee
Duavee is a combination medicine containing estrogen and a drug that blocks estrogen in some parts of the body.
Compare with norethindrone →
cabergoline
Dostinex
Cabergoline is a medicine that helps lower the amount of prolactin in your body.
Compare with norethindrone →
clomiphene
Clomid, Serophene
Clomiphene citrate is a medicine that helps women ovulate.
Compare with norethindrone →
Compare beyond drug class
Nationwide peers by FAERS volume & death-report share
Two PlainMeds-derived comparison paths for norethindrone: nearest FDA FAERS report volume and nearest death-report share among drugs with at least 1,000 logged reports, excluding same-class neighbors listed above. Counts reflect reporting volume, not proven individual harm.
Similar FAERS report volume
Nearest drugs by total FAERS reports. This record: 5,342.
Similar death-report share
Nearest drugs by FAERS death-report share. This record: 1.50%.
- ixekizumab Δ 0.02 pts · 35,897 reports · Anti-IL-17A Monoclonal Antibody 1.47%death share
- cromolyn Δ 0.11 pts · 3,396 reports · Mast Cell Stabilizer 1.38%death share
- pimecrolimus Δ 0.13 pts · 1,541 reports · Calcineurin Inhibitor (Topical) 1.36%death share
- tazarotene Δ 0.17 pts · 1,132 reports · Retinoid (Topical) 1.33%death share
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Narrow Therapeutic Index Drugs
FDA bioequivalence and label-record context for narrow therapeutic index medicines
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Save on norethindrone
Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.
Disclosure: This link may earn us a commission at no extra cost to you. See our terms.
What the FDA Data Shows for norethindrone
The FDA label for norethindrone (sold under brand names such as Camila, Errin) classifies it as a prescription-only medication in the Progestin-Only Oral Contraceptive class. These pills are used to prevent pregnancy. Official labeling lists 9 commonly reported side effects, including Nausea, Vomiting, Gastrointestinal symptoms (like cramps and bloating).
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 5,342 voluntary reports. The database also lists 10 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated major severity. NADAC pricing from CMS shows a generic unit cost of $0.08.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.
Last updated: January 29, 2026
PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages